Free Trial
OTCMKTS:GNBT

Generex Biotechnology (GNBT) Stock Price, News & Analysis

Generex Biotechnology logo

About Generex Biotechnology Stock (OTCMKTS:GNBT)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
60,924 shs
Market Capitalization
$73 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive GNBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Generex Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

GNBT Stock News Headlines

Bloomage Biotechnology
The Coin That Could Define Trump’s Crypto Presidency
When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed. While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.”
Generex Creates Own Regulatory Reality
Generex Plans Reverse Stock Split
Generex Biotechnology Jumps
See More Headlines

GNBT Stock Analysis - Frequently Asked Questions

Shares of GNBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Generex Biotechnology investors own include SELLAS Life Sciences Group (SLS), (UNISQ) (UNISQ), Amgen (AMGN), VBI Vaccines (VBIV), Novavax (NVAX), iBio (IBIO) and Inovio Pharmaceuticals (INO).

Company Calendar

Today
8/08/2025
Fiscal Year End
7/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:GNBT
CIK
1059784
Employees
15
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$2.66 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
122,058,000
Free Float
79,094,000
Market Cap
$73 thousand
Optionable
Not Optionable
Beta
-0.07

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (OTCMKTS:GNBT) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners